{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Clinical development of antibody-based receptor tyrosine kinase inhibitors for cancer therapy",
    "dc:creator": [
        "ZHENPING ZHU",
        "HICKLIN, Daniel J",
        "BOHLEN, Peter",
        "WAKSAL, Harlan",
        "WITTE, Larry"
    ],
    "dc:contributor": "Pandalai, S. G",
    "dc:relation": "Recent research developments in quantum electronics, pp. 369-384",
    "dc:date": "2001",
    "dc:type": [
        "Text",
        "Book Chapter"
    ],
    "dc:language": "English",
    "dc:publisher": "Transworld research network",
    "dc:format": [
        "print",
        "16 p. ; 141 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Cytokine"
        },
        {
            "@xml:lang": "fr",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteur croissance"
        },
        {
            "@xml:lang": "fr",
            "#text": "Polypeptide"
        },
        {
            "@xml:lang": "fr",
            "#text": "Transferases"
        },
        {
            "@xml:lang": "fr",
            "#text": "Anticancéreux"
        },
        {
            "@xml:lang": "fr",
            "#text": "Anticorps monoclonal"
        },
        {
            "@xml:lang": "fr",
            "#text": "Article synthèse"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteur croissance endothélium vasculaire"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteur croissance épiderme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Homme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Immunothérapie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Protein-tyrosine kinase"
        },
        {
            "@xml:lang": "fr",
            "#text": "Récepteur biologique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Traitement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Tumeur maligne"
        },
        {
            "@xml:lang": "en",
            "#text": "Cytokine"
        },
        {
            "@xml:lang": "en",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "en",
            "#text": "Growth factor"
        },
        {
            "@xml:lang": "en",
            "#text": "Polypeptide"
        },
        {
            "@xml:lang": "en",
            "#text": "Transferases"
        },
        {
            "@xml:lang": "en",
            "#text": "Antineoplastic agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Monoclonal antibody"
        },
        {
            "@xml:lang": "en",
            "#text": "Review"
        },
        {
            "@xml:lang": "en",
            "#text": "Vascular endothelium growth factor"
        },
        {
            "@xml:lang": "en",
            "#text": "Epidermal growth factor"
        },
        {
            "@xml:lang": "en",
            "#text": "Human"
        },
        {
            "@xml:lang": "en",
            "#text": "Immunotherapy"
        },
        {
            "@xml:lang": "en",
            "#text": "Protein-tyrosine kinase"
        },
        {
            "@xml:lang": "en",
            "#text": "Biological receptor"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant tumor"
        },
        {
            "@xml:lang": "es",
            "#text": "Citoquina"
        },
        {
            "@xml:lang": "es",
            "#text": "Enzima"
        },
        {
            "@xml:lang": "es",
            "#text": "Factor crecimiento"
        },
        {
            "@xml:lang": "es",
            "#text": "Polipéptido"
        },
        {
            "@xml:lang": "es",
            "#text": "Transferases"
        },
        {
            "@xml:lang": "es",
            "#text": "Anticanceroso"
        },
        {
            "@xml:lang": "es",
            "#text": "Anticuerpo monoclonal"
        },
        {
            "@xml:lang": "es",
            "#text": "Artículo síntesis"
        },
        {
            "@xml:lang": "es",
            "#text": "Factor crecimiento endotelio vascular"
        },
        {
            "@xml:lang": "es",
            "#text": "Factor crecimiento epidermi"
        },
        {
            "@xml:lang": "es",
            "#text": "Hombre"
        },
        {
            "@xml:lang": "es",
            "#text": "Inmunoterapia"
        },
        {
            "@xml:lang": "es",
            "#text": "Protein-tyrosine kinase"
        },
        {
            "@xml:lang": "es",
            "#text": "Receptor biológico"
        },
        {
            "@xml:lang": "es",
            "#text": "Tratamiento"
        },
        {
            "@xml:lang": "es",
            "#text": "Tumor maligno"
        },
        "002B02R03: Immunothérapie / Immunotherapy"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 14558776"
}